JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

Kodu・Aktsiate loetelu・Evolent Health Inc

Evolent Health Inc

Suletud

SektorTervishoid

3.22 -5.01

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.21

Max

3.4699999999999998

Põhinäitajad
By Trading Economics
Sissetulek	30M -21M
Müük	35M 480M
Kasumimarginaal	-4.351
Töötajad	4,500
EBITDA	512K 15M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+151.48% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	19. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	-349M 430M
Eelmine avamishind	8.23
Eelmine sulgemishind	3.22

Uudiste sentiment

By Acuity

25%

75%

47 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

10.33 / 10.95 Toetus ja vastupanu

Evolent Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. jaan 2026, 23:07 UTC

Tulu

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27. jaan 2026, 21:27 UTC

Tulu

Texas Instruments 4Q Sales Rise, Profit Falls

27. jaan 2026, 23:55 UTC

Market Talk

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27. jaan 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. jaan 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27. jaan 2026, 23:39 UTC

Market Talk

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27. jaan 2026, 23:20 UTC

Tulu

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27. jaan 2026, 23:20 UTC

Tulu

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27. jaan 2026, 23:19 UTC

Tulu

SK Innovation Posts Net Loss for Second Consecutive Year

27. jaan 2026, 23:19 UTC

Tulu

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27. jaan 2026, 23:18 UTC

Tulu

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27. jaan 2026, 23:18 UTC

Tulu

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27. jaan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

27. jaan 2026, 23:11 UTC

Market Talk

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27. jaan 2026, 23:07 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27. jaan 2026, 22:17 UTC

Market Talk

U.S. Dollar Slips Following Trump Comments -- Market Talk

27. jaan 2026, 22:06 UTC

Tulu

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27. jaan 2026, 21:51 UTC

Tulu

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. jaan 2026, 21:43 UTC

Tulu

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27. jaan 2026, 21:41 UTC

Tulu

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27. jaan 2026, 21:38 UTC

Tulu

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27. jaan 2026, 21:32 UTC

Tulu

Ampol: Modest Profit From F&I International in 2025

27. jaan 2026, 21:32 UTC

Tulu

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27. jaan 2026, 21:31 UTC

Tulu

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27. jaan 2026, 21:31 UTC

Tulu

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27. jaan 2026, 21:30 UTC

Tulu

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27. jaan 2026, 21:29 UTC

Tulu

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27. jaan 2026, 21:29 UTC

Tulu

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27. jaan 2026, 21:28 UTC

Tulu

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Võrdlus sarnastega

Hinnamuutus

Evolent Health Inc Prognoos

Hinnasiht

By TipRanks

151.48% tõus

12 kuu keskmine prognoos

Keskmine 9.33 USD 151.48%

Kõrge 16 USD

Madal 5 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Evolent Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

14 ratings

Osta

Hoia

Müü

Põhineb 14 analüütiku instrumendi Evolent Health Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

10.33 / 10.95Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

47 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.